114 related articles for article (PubMed ID: 12794567)
21. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
[TBL] [Abstract][Full Text] [Related]
22. Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy.
Goetz MB; Boscardin WJ; Wiley D; Alkasspooles S
AIDS; 2001 Aug; 15(12):1576-9. PubMed ID: 11504992
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
25. Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.
Lange CG; Lederman MM; Medvik K; Asaad R; Wild M; Kalayjian R; Valdez H
AIDS; 2003 Sep; 17(14):2015-23. PubMed ID: 14502004
[TBL] [Abstract][Full Text] [Related]
26. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
27. The predictive role of CD4
Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
[TBL] [Abstract][Full Text] [Related]
28. Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.
Johnston AM; Valentine ME; Ottinger J; Baydo R; Gryszowka V; Vavro C; Weinhold K; St Clair M; McKinney RE
Pediatr Infect Dis J; 2001 Oct; 20(10):941-6. PubMed ID: 11642627
[TBL] [Abstract][Full Text] [Related]
29. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy.
Flynn PM; Rudy BJ; Douglas SD; Lathey J; Spector SA; Martinez J; Silio M; Belzer M; Friedman L; D'Angelo L; McNamara J; Hodge J; Hughes MD; Lindsey JC;
J Infect Dis; 2004 Jul; 190(2):271-9. PubMed ID: 15216461
[TBL] [Abstract][Full Text] [Related]
30. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV.
Grabar S; Kousignian I; Sobel A; Le Bras P; Gasnault J; Enel P; Jung C; Mahamat A; Lang JM; Costagliola D
AIDS; 2004 Oct; 18(15):2029-38. PubMed ID: 15577624
[TBL] [Abstract][Full Text] [Related]
31. Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: analysis of cellular immune responses.
Blazevic V; Jankelevich S; Steinberg SM; Jacobsen F; Yarchoan R; Shearer GM
Clin Diagn Lab Immunol; 2001 Sep; 8(5):943-8. PubMed ID: 11527808
[TBL] [Abstract][Full Text] [Related]
32. CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts.
Geng EH; Deeks SG
Clin Infect Dis; 2009 Feb; 48(3):362-4. PubMed ID: 19123869
[No Abstract] [Full Text] [Related]
33. Thymic Function during 12 Months of Highly Active Antiretroviral Therapy in Thai HIV-Infected Patients with Normal and Slow Immune Recovery.
Kingkeow D; Srithep S; Praparattanapan J; Supparatpinyo K; Pornprasert S
Jpn J Infect Dis; 2015; 68(5):353-6. PubMed ID: 25720642
[TBL] [Abstract][Full Text] [Related]
34. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
[TBL] [Abstract][Full Text] [Related]
35. Decrease in immune activation in HIV-infected patients treated with highly active antiretroviral therapy correlates with the function of hematopoietic progenitor cells and the number of naive CD4+ cells.
Nielsen SD; Sørensen TU; Ersbøll AK; Ngo N; Mathiesen L; Nielsen JO; Hansen JE
Scand J Infect Dis; 2000; 32(6):597-603. PubMed ID: 11200367
[TBL] [Abstract][Full Text] [Related]
36. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
37. Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.
Ferraris L; Bellistri GM; Pegorer V; Tincati C; Meroni L; Galli M; Monforte Ad; Gori A; Marchetti G
Clin Infect Dis; 2008 Jan; 46(1):149-50. PubMed ID: 18171234
[No Abstract] [Full Text] [Related]
38. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
Anthony KB; Yoder C; Metcalf JA; DerSimonian R; Orenstein JM; Stevens RA; Falloon J; Polis MA; Lane HC; Sereti I
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):125-33. PubMed ID: 12794543
[TBL] [Abstract][Full Text] [Related]
39. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
40. Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART.
Ruiz-Mateos E; de la Rosa R; Soriano N; Martinez-Moya M; Rubio A; Sánchez-Quijano A; Lissen E; Leal M
Antivir Ther; 2003 Aug; 8(4):289-94. PubMed ID: 14518697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
